Stephanie Reinert
About Stephanie Reinert
Stephanie Reinert serves as the Area Lead for ALS at Amylyx Pharmaceuticals, a position she has held since 2022. She has extensive experience in the pharmaceutical industry, having worked in various roles at companies such as Biogen and Baxter Deutschland Holding GmbH.
Current Role at Amylyx Pharmaceuticals
Stephanie Reinert serves as the Area Lead for ALS at Amylyx Pharmaceuticals. She has held this position since 2022, contributing to the company's initiatives in the field of amyotrophic lateral sclerosis (ALS) in Germany. Her role involves overseeing regional strategies and ensuring effective communication between the company and healthcare professionals.
Previous Experience at Biogen
Prior to her current position, Stephanie Reinert worked at Biogen in various roles related to neuroscience and rare diseases. She was a Senior Account Manager for SMA from 2019 to 2021, focusing on rare disease management in Norddeutschland. Additionally, she served as a Neuroscience Network Manager for Alzheimer's Disease from 2021 to 2022 and held multiple account management positions in dermatology and multiple sclerosis from 2009 to 2019.
Background in Pharmaceutical Sales
Stephanie Reinert has a robust background in pharmaceutical sales, having worked at several prominent companies. She began her career as a Pharmareferentin at Pharmacia & Upjohn from 1998 to 2000, followed by a five-year tenure at BERLIN-CHEMIE Menarini until 2005. She then joined Baxter Deutschland Holding GmbH as Klinikreferentin Biotherapeutics, Specialty Care, from 2005 to 2008, further solidifying her expertise in the industry.
Education and Professional Development
While specific educational details are not provided, Stephanie Reinert's extensive career in the pharmaceutical industry indicates a strong foundation in relevant scientific and medical knowledge. Her various roles have required continuous professional development, particularly in areas related to biotherapeutics, neurology, and rare diseases.